Chronic obstructive pulmonary disease (COPD) is characterised by persistent airflow limitation that is usually progressive. Additionally, exacerbations and co-existing morbidities contribute to the overall severity in the individual patient [1, 3]. Metabolic syndrome is the name for a group of risk factors that raises the risk for heart disease and other health problems such as, diabetes and stroke. It is present in almost 57% of COPD patients [2]. This is a prospective observational study included 50 patients admitted in chest ward of Sri Ramachandra hospital with Chronic Obstructive Pulmonary Disease, According to guidelines from the national heart, lung, and blood pressure (NHLBI) and the American heart association(AHA), metabolic syndrome is diagnosed, COPD staging with PFT. Each patient was included only once in the study. On admission each patients history was taken regarding occupation, smoking, medication (Inhaled corticosteroids and bronchodilators), number of years of treatment, number of acute exacerbation and number of hospital admission in last year were recorded and tabulated. Height, Weight, BMI, Pulse rate, Respiratory rate and blood pressure, ABG, lipid profile, 6minute walk test, mid arm, mid-thigh and waist circumference were recorded and sent for statistical analysis. Result showed the prevalence of metabolic syndrome in our study was 62% and was associated with severe airflow obstruction and low 6 minute walk distance. Coexisting comorbidities also more frequent in these patients.